Márton Mohás

1.1k total citations · 1 hit paper
21 papers, 890 citations indexed

About

Márton Mohás is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Márton Mohás has authored 21 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Márton Mohás's work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Advanced Glycation End Products research (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Márton Mohás is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Advanced Glycation End Products research (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Márton Mohás collaborates with scholars based in Hungary, United Kingdom and Poland. Márton Mohás's co-authors include István Wittmann, Judit Cseh, G Molnár, Lajos Markó, Boglárka Laczy, István András Szijártó, Esztella Mikolás, Ákos Mérei, Pál Brasnyó and László Mészáros and has published in prestigious journals such as Kidney International, Life Sciences and British Journal Of Nutrition.

In The Last Decade

Márton Mohás

19 papers receiving 870 citations

Hit Papers

Resveratrol improves insulin sensitivity, reduces oxidati... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers

Márton Mohás
Judit Cseh Hungary
Márton Mohás
Citations per year, relative to Márton Mohás Márton Mohás (= 1×) peers Judit Cseh

Countries citing papers authored by Márton Mohás

Since Specialization
Citations

This map shows the geographic impact of Márton Mohás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Márton Mohás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Márton Mohás more than expected).

Fields of papers citing papers by Márton Mohás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Márton Mohás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Márton Mohás. The network helps show where Márton Mohás may publish in the future.

Co-authorship network of co-authors of Márton Mohás

This figure shows the co-authorship network connecting the top 25 collaborators of Márton Mohás. A scholar is included among the top collaborators of Márton Mohás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Márton Mohás. Márton Mohás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bene, Judit, Márton Mohás, Tamás Oroszlán, et al.. (2012). Similarities in Serum Acylcarnitine Patterns in Type 1 and Type 2 Diabetes Mellitus and in Metabolic Syndrome. Annals of Nutrition and Metabolism. 62(1). 80–85. 50 indexed citations
2.
Brasnyó, Pál, G Molnár, Márton Mohás, et al.. (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. British Journal Of Nutrition. 106(3). 383–389. 546 indexed citations breakdown →
3.
Kisfali, Péter, et al.. (2011). Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients. Molecular Biology Reports. 39(2). 1949–1955. 7 indexed citations
4.
Kisfali, Péter, Márton Mohás, Anita Maász, et al.. (2010). Stepwise Positive Association Between APOA5 Minor Allele Frequencies and Increasing Plasma Triglyceride Quartiles in Random Patients with Hypertriglyceridemia of Unclarified Origin. Pathology & Oncology Research. 17(1). 39–44. 4 indexed citations
5.
Mohás, Márton, Péter Kisfali, Luca Járomi, et al.. (2010). GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?. Cardiovascular Diabetology. 9(1). 79–79. 33 indexed citations
6.
Markó, Lajos, G Molnár, Judit Cseh, et al.. (2010). Microalbuminuria in inflammatory bowel diseases using immunoturbidimetry and high-performance liquid chromatography.. PubMed. 72(4). 394–401. 2 indexed citations
7.
Degrell, Péter, Judit Cseh, Márton Mohás, et al.. (2009). Evidence of O-linked N-acetylglucosamine in diabetic nephropathy. Life Sciences. 84(13-14). 389–393. 46 indexed citations
8.
Kisfali, Péter, Márton Mohás, Anita Maász, et al.. (2009). Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutrition Metabolism and Cardiovascular Diseases. 20(7). 505–511. 32 indexed citations
9.
Járomi, Luca, Veronika Csöngei, Noémi Polgár, et al.. (2009). Functional Variants of Glucokinase Regulatory Protein and Apolipoprotein A5 Genes in Ischemic Stroke. Journal of Molecular Neuroscience. 41(1). 121–128. 20 indexed citations
10.
Mohás, Márton, Péter Kisfali, Ákos Mérei, et al.. (2009). A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA1c Levels and the Onset of Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 118(3). 209–212. 24 indexed citations
11.
Kisfali, Péter, Márton Mohás, Anita Maász, et al.. (2008). Apolipoprotein A5 gene APOA5*2 haplotype variant confers risk for the development of metabolic syndrome. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences).
12.
Degrell, Péter, Zoltán Wagner, István András Szijártó, et al.. (2008). Morphology of Glomerular Hematuria Is Reproduced in vitro by Carbonyl Stress. Nephron Experimental Nephrology. 110(1). e25–e30. 2 indexed citations
13.
Laczy, Boglárka, Judit Cseh, Márton Mohás, et al.. (2008). Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus. Acta Diabetologica. 46(2). 105–111. 14 indexed citations
14.
Mohás, Márton, Lajos Markó, G Molnár, et al.. (2008). Serum Total LDH Activity and LDH-2 Isozyme in Nephrotic Syndrome. Kidney & Blood Pressure Research. 31(1). 47–54.
15.
Csiky, Botond, Lajos Markó, Márton Mohás, et al.. (2008). [The pleiotropic effects of losartan--the importance of decreasing uric acid level].. PubMed. 18(10). 663–6. 2 indexed citations
16.
Wittmann, István, G Molnár, László Wagner, et al.. (2007). Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis. Acta Physiologica Hungarica. 94(1-2). 159–166. 2 indexed citations
17.
Wagner, László, Boglárka Laczy, István Mazák, et al.. (2007). Cigarette Smoke-Induced Alterations in Endothelial Nitric Oxide Synthase Phosphorylation: Role of Protein Kinase C. Endothelium. 14(4-5). 245–255. 30 indexed citations
18.
Markó, Lajos, G Molnár, Zoltán Wagner, et al.. (2007). Analysis of microalbuminuria with immunonephelometry and high performance liquid chromatography. Evaluation of new criteria. Orvosi Hetilap. 149(2). 59–67. 5 indexed citations
19.
Wittmann, István, László Wagner, Lajos Markó, et al.. (2007). Importance of hereditary haemochromatosis in the care of diabetes mellitus. Orvosi Hetilap. 148(3). 111–115. 2 indexed citations
20.
Molnár, G, Zoltán Wagner, Lajos Markó, et al.. (2005). Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: Evidence for hydroxyl radical production. Kidney International. 68(5). 2281–2287. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026